{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T03:35:40Z","timestamp":1792553740376,"version":"4.5.0"},"reference-count":154,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1016\/j.cld.2007.08.001","type":"journal-article","created":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T04:49:54Z","timestamp":1196484594000},"page":"727-759","source":"Crossref","is-referenced-by-count":53,"title":["The Immunology of Hepatitis B"],"prefix":"10.1016","volume":"11","author":[{"given":"John M.","family":"Vierling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.cld.2007.08.001_bib1","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/hep.21627","article-title":"Management of hepatitis B: summary of a clinical research workshop","volume":"45","author":"Hoofnagle","year":"2007","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2007.08.001_bib2","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/hep.21513","article-title":"Chronic hepatitis B","volume":"45","author":"Lok","year":"2007","journal-title":"Hepatology"},{"issue":"15","key":"10.1016\/j.cld.2007.08.001_bib3","doi-asserted-by":"crossref","first-page":"9369","DOI":"10.1128\/JVI.79.15.9369-9380.2005","article-title":"Stealth and cunning: hepatitis B and hepatitis C viruses","volume":"79","author":"Wieland","year":"2005","journal-title":"J Virol"},{"issue":"27","key":"10.1016\/j.cld.2007.08.001_bib4","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1038\/sj.onc.1209559","article-title":"Hepatitis B virus-related hepatocellular carcinoma: paradigms for viral-related human carcinogenesis","volume":"25","author":"Kremsdorf","year":"2006","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.cld.2007.08.001_bib5","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3748\/wjg.v13.i1.74","article-title":"Hepatitis B virus-induced oncogenesis","volume":"13","author":"Lupberger","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cld.2007.08.001_bib6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.iy.13.040195.000333","article-title":"Hepatitis B virus immunopathogenesis","volume":"13","author":"Chisari","year":"1995","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"10.1016\/j.cld.2007.08.001_bib7","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/jhep.2003.50310","article-title":"Kinetics of the immune response during HBV and HCV infection","volume":"38","author":"Bertoletti","year":"2003","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2007.08.001_bib8","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/jmv.10096","article-title":"Viral determinants and host immune responses in the pathogenesis of HBV infection","volume":"67","author":"Rapicetta","year":"2002","journal-title":"J Med Virol"},{"issue":"2","key":"10.1016\/j.cld.2007.08.001_bib9","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1055\/s-2007-979468","article-title":"Chronic infections with hepatotropic viruses: mechanisms of impairment of cellular immune responses","volume":"27","author":"Rehermann","year":"2007","journal-title":"Semin Liver Dis"},{"issue":"2","key":"10.1016\/j.cld.2007.08.001_bib10","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2005.12.022","article-title":"Analysis of intrahepatic HBV-specific cytotoxic T-cells during and after acute HBV infection in humans","volume":"45","author":"Sprengers","year":"2006","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2007.08.001_bib11","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1046\/j.1365-2893.2003.00412.x","article-title":"The role of intrahepatic immune effector cells in inflammatory liver injury and viral control during chronic hepatitis B infection","volume":"10","author":"Tang","year":"2003","journal-title":"J Viral Hepat"},{"issue":"1","key":"10.1016\/j.cld.2007.08.001_bib12","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/BF02256004","article-title":"Activation of Th1 immunity is a common immune mechanism for the successful treatment of hepatitis B and C: tetramer assay and therapeutic implications","volume":"10","author":"Tsai","year":"2003","journal-title":"J Biomed Sci"},{"issue":"Suppl 4","key":"10.1016\/j.cld.2007.08.001_bib13","doi-asserted-by":"crossref","first-page":"A80","DOI":"10.1016\/S0264-410X(02)00392-4","article-title":"The role of cytotoxic T cells and cytokines in the control of hepatitis B virus infection","volume":"20","author":"Guidotti","year":"2002","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.cld.2007.08.001_bib14","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1084\/jem.20061287","article-title":"Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage","volume":"204","author":"Dunn","year":"2007","journal-title":"J Exp Med"},{"issue":"12","key":"10.1016\/j.cld.2007.08.001_bib15","doi-asserted-by":"crossref","first-page":"5692","DOI":"10.4049\/jimmunol.158.12.5692","article-title":"Differential target cell sensitivity to CTL-activated death pathways in hepatitis B virus transgenic mice","volume":"158","author":"Nakamoto","year":"1997","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.cld.2007.08.001_bib16","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.4049\/jimmunol.164.8.4235","article-title":"Ongoing murine T1 or T2 immune responses to the hepatitis B surface antigen are excluded from the liver that expresses transgene-encoded hepatitis B surface antigen","volume":"164","author":"Schirmbeck","year":"2000","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.cld.2007.08.001_bib17","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.4049\/jimmunol.166.2.1389","article-title":"Overcoming T cell tolerance to the hepatitis B virus surface antigen in hepatitis B virus-transgenic mice","volume":"166","author":"Sette","year":"2001","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.cld.2007.08.001_bib18","doi-asserted-by":"crossref","first-page":"4520","DOI":"10.4049\/jimmunol.161.9.4520","article-title":"Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice","volume":"161","author":"Shimizu","year":"1998","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.cld.2007.08.001_bib19","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1128\/JVI.77.2.1227-1236.2003","article-title":"Searching for interferon-induced genes that inhibit hepatitis B virus replication in transgenic mouse hepatocytes","volume":"77","author":"Wieland","year":"2003","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.cld.2007.08.001_bib20","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.1128\/JVI.74.9.4165-4173.2000","article-title":"Intrahepatic induction of alpha\/beta interferon eliminates viral RNA-containing capsids in hepatitis B virus transgenic mice","volume":"74","author":"Wieland","year":"2000","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.cld.2007.08.001_bib21","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jtbi.2007.02.017","article-title":"Modeling the mechanisms of acute hepatitis B virus infection","volume":"247","author":"Ciupe","year":"2007","journal-title":"J Theor Biol"},{"issue":"12","key":"10.1016\/j.cld.2007.08.001_bib22","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.1073\/pnas.0603626104","article-title":"The role of cells refractory to productive infection in acute hepatitis B viral dynamics","volume":"104","author":"Ciupe","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.cld.2007.08.001_bib23","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1056\/NEJM200008033430506","article-title":"Innate immunity","volume":"343","author":"Medzhitov","year":"2000","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.cld.2007.08.001_bib24","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/sj.cr.7310019","article-title":"Antiviral innate immunity pathways","volume":"16","author":"Seth","year":"2006","journal-title":"Cell Res"},{"issue":"2","key":"10.1016\/j.cld.2007.08.001_bib25","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1309\/N0C70VCU3EHL57WK","article-title":"Innate immunity: New approaches to understanding its clinical significance","volume":"123","author":"Staros","year":"2005","journal-title":"Am J Clin Pathol"},{"issue":"Suppl 1","key":"10.1016\/j.cld.2007.08.001_bib26","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.vaccine.2004.08.013","article-title":"Innate immune responses during infection","volume":"22","author":"Ulevitch","year":"2004","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.cld.2007.08.001_bib27","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1056\/NEJM200007063430107","article-title":"The immune system. First of two parts","volume":"343","author":"Delves","year":"2000","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.cld.2007.08.001_bib28","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1056\/NEJM200007133430207","article-title":"The immune system. Second of two parts","volume":"343","author":"Delves","year":"2000","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.cld.2007.08.001_bib29","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.intimp.2006.02.005","article-title":"Therapeutic targeting of pattern-recognition receptors","volume":"6","author":"Rezaei","year":"2006","journal-title":"Int Immunopharmacol"},{"issue":"7","key":"10.1016\/j.cld.2007.08.001_bib30","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nri1396","article-title":"Therapeutics targeting the innate immune system","volume":"4","author":"Ulevitch","year":"2004","journal-title":"Nat Rev Immunol"},{"issue":"14","key":"10.1016\/j.cld.2007.08.001_bib31","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJM200104053441406","article-title":"Complement. First of two parts","volume":"344","author":"Walport","year":"2001","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.cld.2007.08.001_bib32","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJM200104123441506","article-title":"Complement. Second of two parts","volume":"344","author":"Walport","year":"2001","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.cld.2007.08.001_bib33","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMra052723","article-title":"The many roles of chemokines and chemokine receptors in inflammation","volume":"354","author":"Charo","year":"2006","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.cld.2007.08.001_bib34","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.cytogfr.2005.03.004","article-title":"Chemokines provide the sustained inflammatory bridge between innate and acquired immunity","volume":"16","author":"Coelho","year":"2005","journal-title":"Cytokine Growth Factor Rev"},{"issue":"10","key":"10.1016\/j.cld.2007.08.001_bib35","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1056\/NEJM200009073431006","article-title":"The HLA system. First of two parts","volume":"343","author":"Klein","year":"2000","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.cld.2007.08.001_bib36","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1056\/NEJM200009143431106","article-title":"The HLA system. Second of two parts","volume":"343","author":"Klein","year":"2000","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.cld.2007.08.001_bib37","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nri2061","article-title":"FOXP3 modifies the phenotypic and functional properties of regulatory T cells","volume":"7","author":"Campbell","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.cld.2007.08.001_bib38","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.0105-2896.2006.00414.x","article-title":"Regulatory T cells in the periphery","volume":"212","author":"Lohr","year":"2006","journal-title":"Immunol Rev"},{"key":"10.1016\/j.cld.2007.08.001_bib39","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1600-065X.2006.00445.x","article-title":"The role of regulatory T cells in the control of natural killer cells: relevance during tumor progression","volume":"214","author":"Ghiringhelli","year":"2006","journal-title":"Immunol Rev"},{"key":"10.1016\/j.cld.2007.08.001_bib40","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.0105-2896.2006.00416.x","article-title":"Role of TCR specificity in CD4+ CD25+ regulatory T-cell selection","volume":"212","author":"Picca","year":"2006","journal-title":"Immunol Rev"},{"issue":"6","key":"10.1016\/j.cld.2007.08.001_bib41","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1139\/o05-146","article-title":"A molecular view of cytotoxic T lymphocyte induced killing","volume":"83","author":"Bleackley","year":"2005","journal-title":"Biochem Cell Biol"},{"issue":"10","key":"10.1016\/j.cld.2007.08.001_bib42","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/nri911","article-title":"Functional significance of the perforin\/granzyme cell death pathway","volume":"2","author":"Trapani","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.cld.2007.08.001_bib43","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/0-387-26283-0_7","article-title":"CD95L\/FasL and TRAIL in tumour surveillance and cancer therapy","volume":"130","author":"Wajant","year":"2006","journal-title":"Cancer Treat Res"},{"issue":"6","key":"10.1016\/j.cld.2007.08.001_bib44","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.bcp.2004.05.043","article-title":"Cytotoxic lymphocytes; instigators of dramatic target cell death","volume":"68","author":"Waterhouse","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.cld.2007.08.001_bib45","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.2741\/1285","article-title":"Interactive protrusive structures during leukocyte adhesion and transendothelial migration","volume":"9","author":"Barreiro","year":"2004","journal-title":"Front Biosci"},{"issue":"5","key":"10.1016\/j.cld.2007.08.001_bib46","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1002\/hep.21378","article-title":"T lymphocytes interact with hepatocytes through fenestrations in murine liver sinusoidal endothelial cells","volume":"44","author":"Warren","year":"2006","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2007.08.001_bib47","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1055\/s-2007-979466","article-title":"The immunological milieu of the liver","volume":"27","author":"Selmi","year":"2007","journal-title":"Semin Liver Dis"},{"issue":"1","key":"10.1016\/j.cld.2007.08.001_bib48","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-2249.2007.03415.x","article-title":"The activation state of human intrahepatic lymphocytes","volume":"149","author":"Tu","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cld.2007.08.001_bib49","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/3-540-27743-9_5","article-title":"The CD2 family of natural killer cell receptors","volume":"298","author":"McNerney","year":"2006","journal-title":"Curr Top Microbiol Immunol"},{"issue":"7","key":"10.1016\/j.cld.2007.08.001_bib50","doi-asserted-by":"crossref","first-page":"103R","DOI":"10.1093\/glycob\/cwj111","article-title":"T-cell recognition of glycolipids presented by CD1 proteins","volume":"16","author":"Young","year":"2006","journal-title":"Glycobiology"},{"issue":"1","key":"10.1016\/j.cld.2007.08.001_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2567.2005.02256.x","article-title":"Putting the natural killer cell in its place","volume":"117","author":"O'Connor","year":"2006","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.cld.2007.08.001_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clim.2005.10.011","article-title":"Natural killer cells in human health and disease","volume":"118","author":"Orange","year":"2006","journal-title":"Clin Immunol"},{"issue":"5","key":"10.1016\/j.cld.2007.08.001_bib53","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.coi.2004.07.010","article-title":"Killer immunoglobulin-like receptors","volume":"16","author":"Moretta","year":"2004","journal-title":"Curr Opin Immunol"},{"issue":"9","key":"10.1016\/j.cld.2007.08.001_bib54","doi-asserted-by":"crossref","first-page":"5222","DOI":"10.4049\/jimmunol.172.9.5222","article-title":"Passive and active mechanisms trap activated CD8+ T cells in the liver","volume":"172","author":"John","year":"2004","journal-title":"J\u00a0Immunol"},{"issue":"1","key":"10.1016\/j.cld.2007.08.001_bib55","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1046\/j.1440-1711.2002.01065.x","article-title":"Biology and significance of T-cell apoptosis in the liver","volume":"80","author":"Park","year":"2002","journal-title":"Immunol Cell Biol"},{"issue":"3","key":"10.1016\/j.cld.2007.08.001_bib56","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.4049\/jimmunol.175.3.1643","article-title":"TLR-4 regulates CD8+ T cell trapping in the liver","volume":"175","author":"John","year":"2005","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.cld.2007.08.001_bib57","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.4049\/jimmunol.173.4.2402","article-title":"TNF-alpha controls intrahepatic T cell apoptosis and peripheral T cell numbers","volume":"173","author":"Murray","year":"2004","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.cld.2007.08.001_bib58","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1053\/gast.2002.36058","article-title":"Cytokine-dependent bystander hepatitis due to intrahepatic murine CD8 T-cell activation by bone marrow-derived cells","volume":"123","author":"Bowen","year":"2002","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.cld.2007.08.001_bib59","doi-asserted-by":"crossref","first-page":"5430","DOI":"10.4049\/jimmunol.166.9.5430","article-title":"Antigen-specific primary activation of CD8+ T cells within the liver","volume":"166","author":"Bertolino","year":"2001","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.cld.2007.08.001_bib60","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.4049\/jimmunol.177.3.1689","article-title":"Local intrahepatic CD8+ T cell activation by a non-self-antigen results in full functional differentiation","volume":"177","author":"Wuensch","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.cld.2007.08.001_bib61","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.0105-2896.2005.00301.x","article-title":"Cross-presentation: underlying mechanisms and role in immune surveillance","volume":"207","author":"Rock","year":"2005","journal-title":"Immunol Rev"},{"issue":"1","key":"10.1016\/j.cld.2007.08.001_bib62","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/hep.20504","article-title":"Fas and TNFR1, but not cytolytic granule-dependent mechanisms, mediate clearance of murine liver adenoviral infection","volume":"41","author":"Abougergi","year":"2005","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2007.08.001_bib63","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1189\/jlb.0103035","article-title":"The role of TNF-TNFR2 interactions in generation of CTL responses and clearance of hepatic adenovirus infection","volume":"74","author":"Kafrouni","year":"2003","journal-title":"J Leukoc Biol"},{"issue":"10","key":"10.1016\/j.cld.2007.08.001_bib64","doi-asserted-by":"crossref","first-page":"6453","DOI":"10.4049\/jimmunol.172.10.6453","article-title":"Antiviral cytokines induce hepatic expression of the granzyme B inhibitors, proteinase inhibitor 9 and serine proteinase inhibitor 6","volume":"172","author":"Barrie","year":"2004","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.cld.2007.08.001_bib65","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1084\/jem.20051775","article-title":"Complete differentiation of CD8+ T cells activated locally within the transplanted liver","volume":"203","author":"Klein","year":"2006","journal-title":"J Exp Med"},{"issue":"1 Suppl","key":"10.1016\/j.cld.2007.08.001_bib66","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.jhep.2005.11.005","article-title":"Virology of hepatitis B and C viruses and antiviral targets","volume":"44","author":"Pawlotsky","year":"2006","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2007.08.001_bib67","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/0042-6822(88)90127-4","article-title":"The glucocorticoid receptor recognizes a specific nucleotide sequence in hepatitis B virus DNA causing increased activity of the HBV enhancer","volume":"167","author":"Tur-Kaspa","year":"1988","journal-title":"Virology"},{"issue":"6","key":"10.1016\/j.cld.2007.08.001_bib68","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1073\/pnas.83.6.1627","article-title":"Hepatitis B virus DNA contains a glucocorticoid-responsive element","volume":"83","author":"Tur-Kaspa","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"10.1016\/j.cld.2007.08.001_bib69","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.3748\/wjg.v12.i7.1043","article-title":"Screening and identification of interacting proteins with hepatitis B virus core protein in leukocytes and cloning of new gene C1","volume":"12","author":"Lin","year":"2006","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10.1016\/j.cld.2007.08.001_bib70","doi-asserted-by":"crossref","first-page":"4804","DOI":"10.1128\/JVI.71.6.4804-4808.1997","article-title":"Hepatitis B virus replication is cell cycle independent during liver regeneration in transgenic mice","volume":"71","author":"Guidotti","year":"1997","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.cld.2007.08.001_bib71","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/hep.21364","article-title":"The half-life of hepatitis B virions","volume":"44","author":"Murray","year":"2006","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.cld.2007.08.001_bib72","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/nm1317","article-title":"Platelets mediate cytotoxic T lymphocyte-induced liver damage","volume":"11","author":"Iannacone","year":"2005","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.cld.2007.08.001_bib73","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1053\/jhep.2000.19324","article-title":"Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms","volume":"32","author":"Webster","year":"2000","journal-title":"Hepatology"},{"issue":"17","key":"10.1016\/j.cld.2007.08.001_bib74","doi-asserted-by":"crossref","first-page":"6669","DOI":"10.1073\/pnas.0401771101","article-title":"Genomic analysis of the host response to hepatitis B virus infection","volume":"101","author":"Wieland","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"10.1016\/j.cld.2007.08.001_bib75","doi-asserted-by":"crossref","first-page":"7269","DOI":"10.1128\/JVI.79.11.7269-7272.2005","article-title":"Toll-like receptor signaling inhibits hepatitis B virus replication in vivo","volume":"79","author":"Isogawa","year":"2005","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.cld.2007.08.001_bib76","doi-asserted-by":"crossref","first-page":"5188","DOI":"10.4049\/jimmunol.169.9.5188","article-title":"Activated intrahepatic antigen-presenting cells inhibit hepatitis B virus replication in the liver of transgenic mice","volume":"169","author":"Kimura","year":"2002","journal-title":"J Immunol"},{"issue":"21","key":"10.1016\/j.cld.2007.08.001_bib77","doi-asserted-by":"crossref","first-page":"10702","DOI":"10.1128\/JVI.76.21.10702-10707.2002","article-title":"Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice","volume":"76","author":"Kimura","year":"2002","journal-title":"J Virol"},{"issue":"11","key":"10.1016\/j.cld.2007.08.001_bib78","doi-asserted-by":"crossref","first-page":"5646","DOI":"10.1128\/JVI.76.11.5646-5653.2002","article-title":"Cytokine-sensitive replication of hepatitis B virus in immortalized mouse hepatocyte cultures","volume":"76","author":"Pasquetto","year":"2002","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.cld.2007.08.001_bib79","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1128\/JVI.77.1.68-76.2003","article-title":"CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection","volume":"77","author":"Thimme","year":"2003","journal-title":"J Virol"},{"issue":"28","key":"10.1016\/j.cld.2007.08.001_bib80","doi-asserted-by":"crossref","first-page":"9913","DOI":"10.1073\/pnas.0504273102","article-title":"Interferon prevents formation of replication-competent hepatitis B virus RNA-containing nucleocapsids","volume":"102","author":"Wieland","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Suppl 1","key":"10.1016\/j.cld.2007.08.001_bib81","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/S0168-8278(03)00137-5","article-title":"Immunopathogenesis of hepatitis B","volume":"39","author":"Ferrari","year":"2003","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2007.08.001_bib82","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S0168-8278(01)00048-4","article-title":"Identification of hepatitis B virus-specific CTL epitopes presented by HLA-A\u22172402, the most common HLA class I allele in East Asia","volume":"34","author":"Sobao","year":"2001","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2007.08.001_bib83","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.imlet.2004.01.002","article-title":"Frequencies of epitope-specific cytotoxic T lymphocytes in active chronic viral hepatitis B infection by using MHC class I peptide tetramers","volume":"92","author":"Wu","year":"2004","journal-title":"Immunol Lett"},{"issue":"31\u201332","key":"10.1016\/j.cld.2007.08.001_bib84","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1016\/S0264-410X(02)00297-9","article-title":"HLA-A2 1 restricted peptides from the HBx antigen induce specific CTL responses in vitro and in vivo","volume":"20","author":"Hwang","year":"2002","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.cld.2007.08.001_bib85","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/hep.20716","article-title":"Molecular analysis of HLA class II associations with hepatitis B virus clearance and vaccine nonresponsiveness","volume":"41","author":"Godkin","year":"2005","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.cld.2007.08.001_bib86","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00251-006-0131-4","article-title":"Detailed characterization of the peptide binding specificity of five common Patr class I MHC molecules","volume":"58","author":"Sidney","year":"2006","journal-title":"Immunogenetics"},{"issue":"1","key":"10.1016\/j.cld.2007.08.001_bib87","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1128\/JVI.73.1.474-481.1999","article-title":"Hepatitis B virus RNA-binding proteins associated with cytokine-induced clearance of viral RNA from the liver of transgenic mice","volume":"73","author":"Heise","year":"1999","journal-title":"J\u00a0Virol"},{"issue":"6","key":"10.1016\/j.cld.2007.08.001_bib88","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1073\/pnas.0308340100","article-title":"Signal transduction pathways that inhibit hepatitis B virus replication","volume":"101","author":"Robek","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"10.1016\/j.cld.2007.08.001_bib89","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1128\/JVI.76.7.3570-3574.2002","article-title":"Inhibition of hepatitis B virus replication by interferon requires proteasome activity","volume":"76","author":"Robek","year":"2002","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.cld.2007.08.001_bib90","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1074-7613(00)80295-2","article-title":"Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes","volume":"4","author":"Guidotti","year":"1996","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.cld.2007.08.001_bib91","doi-asserted-by":"crossref","first-page":"3764","DOI":"10.1073\/pnas.91.9.3764","article-title":"Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice","volume":"91","author":"Guidotti","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.cld.2007.08.001_bib92","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1369-5274(99)80068-X","article-title":"Cytokine-induced viral purging\u2014role in viral pathogenesis","volume":"2","author":"Guidotti","year":"1999","journal-title":"Curr Opin Microbiol"},{"issue":"2","key":"10.1016\/j.cld.2007.08.001_bib93","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1006\/viro.2000.0442","article-title":"Cytokine-mediated control of viral infections","volume":"273","author":"Guidotti","year":"2000","journal-title":"Virology"},{"issue":"5","key":"10.1016\/j.cld.2007.08.001_bib94","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1128\/JVI.74.5.2255-2264.2000","article-title":"Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines","volume":"74","author":"McClary","year":"2000","journal-title":"J Virol"},{"issue":"5415","key":"10.1016\/j.cld.2007.08.001_bib95","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1126\/science.284.5415.825","article-title":"Viral clearance without destruction of infected cells during acute HBV infection","volume":"284","author":"Guidotti","year":"1999","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.cld.2007.08.001_bib96","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1084\/jem.194.12.1755","article-title":"Blocking chemokine responsive to gamma-2\/interferon (IFN)-gamma inducible protein and monokine induced by IFN-gamma activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes","volume":"194","author":"Kakimi","year":"2001","journal-title":"J Exp Med"},{"issue":"21","key":"10.1016\/j.cld.2007.08.001_bib97","first-page":"13759","article-title":"Hepatitis B virus X protein transactivates human interleukin-8 gene through acting on nuclear factor kB and CCAAT\/enhancer-binding protein-like cis-elements","volume":"266","author":"Mahe","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"issue":"21","key":"10.1016\/j.cld.2007.08.001_bib98","doi-asserted-by":"crossref","first-page":"13717","DOI":"10.1073\/pnas.172521999","article-title":"Depletion of neutrophils blocks the recruitment of antigen-nonspecific cells into the liver without affecting the antiviral activity of hepatitis B virus-specific cytotoxic T lymphocytes","volume":"99","author":"Sitia","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"10.1016\/j.cld.2007.08.001_bib99","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1172\/JCI200421087","article-title":"MMPs are required for recruitment of antigen-nonspecific mononuclear cells into the liver by CTLs","volume":"113","author":"Sitia","year":"2004","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.cld.2007.08.001_bib100","doi-asserted-by":"crossref","first-page":"34","DOI":"10.7326\/0003-4819-89-1-34","article-title":"Urticaria associated with acute viral hepatitis type B: studies of pathogenesis","volume":"89","author":"Dienstag","year":"1978","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.cld.2007.08.001_bib101","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1385\/CRIAI:30:1:025","article-title":"Urticaria and hepatitis","volume":"30","author":"Cribier","year":"2006","journal-title":"Clin Rev Allergy Immunol"},{"issue":"9","key":"10.1016\/j.cld.2007.08.001_bib102","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1172\/JCI0214698","article-title":"Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis","volume":"109","author":"Kita","year":"2002","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.cld.2007.08.001_bib103","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.4049\/jimmunol.161.3.1163","article-title":"B lymphocytes are crucial antigen-presenting cells in the pathogenic autoimmune response to GAD65 antigen in nonobese diabetic mice","volume":"161","author":"Falcone","year":"1998","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.cld.2007.08.001_bib104","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/ard.2005.043257","article-title":"Hepatitis B virus (HBV) reactivation with immunosuppressive therapy in rheumatic diseases: assessment and preventive strategies","volume":"65","author":"Calabrese","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.cld.2007.08.001_bib105","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.cgh.2006.05.027","article-title":"Hepatitis B virus reactivation after cytotoxic chemotherapy: the disease and its prevention","volume":"4","author":"Mindikoglu","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2007.08.001_bib106","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1478-3231.2004.0982.x","article-title":"Vigorous response of cytotoxic T lymphocytes associated with systemic activation of CD8 T lymphocytes in fulminant hepatitis B","volume":"24","author":"Kondo","year":"2004","journal-title":"Liver Int"},{"issue":"4","key":"10.1016\/j.cld.2007.08.001_bib107","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/hep.20649","article-title":"Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection","volume":"41","author":"Stoop","year":"2005","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2007.08.001_bib108","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.immuni.2005.05.005","article-title":"Oscillating CD8(+) T cell effector functions after antigen recognition in the liver","volume":"23","author":"Isogawa","year":"2005","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.cld.2007.08.001_bib109","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1007\/s00535-003-1180-1","article-title":"An outbreak of fulminant hepatitis B in immunocompromised hemodialysis patients","volume":"38","author":"Igaki","year":"2003","journal-title":"J Gastroenterol"},{"issue":"2","key":"10.1016\/j.cld.2007.08.001_bib110","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1053\/jhep.2001.26516","article-title":"A dominant hepatitis B virus population defective in virus secretion because of several S-gene mutations from a patient with fulminant hepatitis","volume":"34","author":"Kalinina","year":"2001","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2007.08.001_bib111","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1053\/jhep.2001.23045","article-title":"Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy","volume":"33","author":"Boni","year":"2001","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2007.08.001_bib112","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0168-8278(03)00292-7","article-title":"Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B","volume":"39","author":"Boni","year":"2003","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2007.08.001_bib113","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/jmv.20194","article-title":"Recovery of functional cytotoxic T lymphocytes during lamivudine therapy by acquiring multi-specificity","volume":"74","author":"Kondo","year":"2004","journal-title":"J Med Virol"},{"issue":"3","key":"10.1016\/j.cld.2007.08.001_bib114","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1084\/jem.180.3.933","article-title":"Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope","volume":"180","author":"Bertoletti","year":"1994","journal-title":"J Exp Med"},{"issue":"6479","key":"10.1016\/j.cld.2007.08.001_bib115","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/369407a0","article-title":"Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells","volume":"369","author":"Bertoletti","year":"1994","journal-title":"Nature"},{"issue":"8711","key":"10.1016\/j.cld.2007.08.001_bib116","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0140-6736(90)91874-A","article-title":"Vaccine-induced escape mutant of hepatitis B virus","volume":"336","author":"Carman","year":"1990","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.cld.2007.08.001_bib117","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1086\/516447","article-title":"Hepatitis B virus core protein mutations are concentrated in B cell epitopes in progressive disease and in T helper cell epitopes during clinical remission","volume":"175","author":"Carman","year":"1997","journal-title":"J Infect Dis"},{"issue":"Pt 6","key":"10.1016\/j.cld.2007.08.001_bib118","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1099\/0022-1317-77-6-1129","article-title":"Novel pre-C\/C gene mutants of hepatitis B virus in chronic active hepatitis: naturally occurring escape mutants","volume":"77","author":"Lee","year":"1996","journal-title":"J Gen Virol"},{"issue":"1","key":"10.1016\/j.cld.2007.08.001_bib119","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1006\/viro.1995.1463","article-title":"Core antigen mutations of human hepatitis B virus in hepatomas accumulate in MHC class II-restricted T cell epitopes","volume":"212","author":"Hosono","year":"1995","journal-title":"Virology"},{"issue":"11","key":"10.1016\/j.cld.2007.08.001_bib120","doi-asserted-by":"crossref","first-page":"5842","DOI":"10.4049\/jimmunol.161.11.5842","article-title":"Polyclonality and multispecificity of the CTL response to a single viral epitope","volume":"161","author":"Ishikawa","year":"1998","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.cld.2007.08.001_bib121","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1002\/1521-4141(200011)30:11<3067::AID-IMMU3067>3.0.CO;2-L","article-title":"T cell receptor usage of virus-specific CD8 cells and recognition of viral mutations during acute and persistent hepatitis B virus infection","volume":"30","author":"Maini","year":"2000","journal-title":"Eur J Immunol"},{"issue":"3","key":"10.1016\/j.cld.2007.08.001_bib122","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1172\/JCI118191","article-title":"Hepatitis B virus (HBV) sequence variation of cytotoxic T lymphocyte epitopes is not common in patients with chronic HBV infection","volume":"96","author":"Rehermann","year":"1995","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.cld.2007.08.001_bib123","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1172\/JCI116148","article-title":"Loss of the common \u201cA\u201d determinant of hepatitis B surface antigen by a vaccine-induced escape mutant","volume":"90","author":"Waters","year":"1992","journal-title":"J Clin Invest"},{"issue":"17","key":"10.1016\/j.cld.2007.08.001_bib124","doi-asserted-by":"crossref","first-page":"6599","DOI":"10.1073\/pnas.87.17.6599","article-title":"Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero?","volume":"87","author":"Milich","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.cld.2007.08.001_bib125","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1128\/JVI.79.5.3016-3027.2005","article-title":"Immune tolerance split between hepatitis B virus precore and core proteins","volume":"79","author":"Chen","year":"2005","journal-title":"J Virol"},{"issue":"41","key":"10.1016\/j.cld.2007.08.001_bib126","doi-asserted-by":"crossref","first-page":"14913","DOI":"10.1073\/pnas.0406282101","article-title":"A function of the hepatitis B virus precore protein is to regulate the immune response to the core antigen","volume":"101","author":"Chen","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"10.1016\/j.cld.2007.08.001_bib127","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1084\/jem.20011723","article-title":"Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection","volume":"195","author":"Reignat","year":"2002","journal-title":"J Exp Med"},{"issue":"11","key":"10.1016\/j.cld.2007.08.001_bib128","doi-asserted-by":"crossref","first-page":"5707","DOI":"10.1128\/JVI.78.11.5707-5719.2004","article-title":"Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy","volume":"78","author":"Webster","year":"2004","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.cld.2007.08.001_bib129","doi-asserted-by":"crossref","first-page":"7231","DOI":"10.1128\/JVI.73.9.7231-7240.1999","article-title":"Hepatitis B virus X protein is both a substrate and a potential inhibitor of the proteasome complex","volume":"73","author":"Hu","year":"1999","journal-title":"J Virol"},{"issue":"23","key":"10.1016\/j.cld.2007.08.001_bib130","doi-asserted-by":"crossref","first-page":"11441","DOI":"10.1073\/pnas.89.23.11441","article-title":"Up-regulation of intercellular adhesion molecule 1 transcription by hepatitis B virus X protein","volume":"89","author":"Hu","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"issue":"18","key":"10.1016\/j.cld.2007.08.001_bib131","doi-asserted-by":"crossref","first-page":"7140","DOI":"10.1073\/pnas.87.18.7140","article-title":"Trans-activation of HLA-DR gene by hepatitis B virus X gene product","volume":"87","author":"Hu","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.cld.2007.08.001_bib132","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1053\/gast.2001.22461","article-title":"Acute flares in chronic hepatitis B: the natural and unnatural history of an immunologically mediated liver disease","volume":"120","author":"Perrillo","year":"2001","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.cld.2007.08.001_bib133","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/emm.2006.82","article-title":"Association of common promoter polymorphisms of MCP1 with hepatitis B virus clearance","volume":"38","author":"Park","year":"2006","journal-title":"Exp Mol Med"},{"issue":"2","key":"10.1016\/j.cld.2007.08.001_bib134","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1128\/JVI.01897-06","article-title":"Genetic protection against hepatitis B virus conferred by CCR5Delta32: Evidence that CCR5 contributes to viral persistence","volume":"81","author":"Thio","year":"2007","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.cld.2007.08.001_bib135","doi-asserted-by":"crossref","first-page":"630","DOI":"10.3748\/wjg.v12.i4.630","article-title":"Cytotoxic T-lymphocyte antigen 4 gene polymorphisms and susceptibility to chronic hepatitis B","volume":"12","author":"Mohammad Alizadeh","year":"2006","journal-title":"World J Gastroenterol"},{"issue":"20","key":"10.1016\/j.cld.2007.08.001_bib136","doi-asserted-by":"crossref","first-page":"11258","DOI":"10.1128\/JVI.78.20.11258-11262.2004","article-title":"Cytotoxic T-lymphocyte antigen 4 gene and recovery from hepatitis B virus infection","volume":"78","author":"Thio","year":"2004","journal-title":"J Virol"},{"issue":"8","key":"10.1016\/j.cld.2007.08.001_bib137","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1128\/JVI.02844-06","article-title":"Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection","volume":"81","author":"Boni","year":"2007","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.cld.2007.08.001_bib138","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.4049\/jimmunol.178.5.2714","article-title":"PD-1:PD-L1 interactions contribute to the functional suppression of virus-specific CD8+ T lymphocytes in the liver","volume":"178","author":"Maier","year":"2007","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.cld.2007.08.001_bib139","doi-asserted-by":"crossref","first-page":"739","DOI":"10.4049\/jimmunol.177.1.739","article-title":"Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B","volume":"177","author":"Xu","year":"2006","journal-title":"J Immunol"},{"issue":"8663","key":"10.1016\/j.cld.2007.08.001_bib140","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S0140-6736(89)90713-7","article-title":"Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection","volume":"2","author":"Carman","year":"1989","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.cld.2007.08.001_bib141","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1172\/JCI115590","article-title":"Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion","volume":"89","author":"Tsai","year":"1992","journal-title":"J Clin Invest"},{"issue":"12","key":"10.1016\/j.cld.2007.08.001_bib142","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1172\/JCI119498","article-title":"Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B","volume":"99","author":"Rossol","year":"1997","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.cld.2007.08.001_bib143","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1056\/NEJM199008023230503","article-title":"A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group","volume":"323","author":"Perrillo","year":"1990","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.cld.2007.08.001_bib144","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jhep.2006.10.007","article-title":"Occult hepatitis B virus infection","volume":"46","author":"Raimondo","year":"2007","journal-title":"J Hepatol"},{"issue":"Suppl 1","key":"10.1016\/j.cld.2007.08.001_bib145","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/S1386-6532(05)80005-8","article-title":"Clinical impact of occult HBV infections","volume":"34","author":"Chemin","year":"2005","journal-title":"J Clin Virol"},{"issue":"7","key":"10.1016\/j.cld.2007.08.001_bib146","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/j.1365-2036.2006.03081.x","article-title":"Systematic review: lamivudine prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection","volume":"24","author":"Kohrt","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"issue":"7757","key":"10.1016\/j.cld.2007.08.001_bib147","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S0140-6736(72)91534-6","article-title":"Serum-sickness-like prodromata in viral hepatitis: Caroli's triad","volume":"1","author":"Caroli","year":"1972","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.cld.2007.08.001_bib148","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.cld.2004.02.003","article-title":"Extrahepatic manifestations of chronic hepatitis B","volume":"8","author":"Han","year":"2004","journal-title":"Clin Liver Dis"},{"issue":"1","key":"10.1016\/j.cld.2007.08.001_bib149","doi-asserted-by":"crossref","first-page":"41","DOI":"10.7150\/ijms.2.41","article-title":"Management of HBV infection in liver transplantation patients","volume":"2","author":"Vierling","year":"2005","journal-title":"Int J Med Sci"},{"issue":"4","key":"10.1016\/j.cld.2007.08.001_bib150","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00007890-200002270-00017","article-title":"Immunopathogenesis of hepatitis B virus recurrence after liver transplantation","volume":"69","author":"Marinos","year":"2000","journal-title":"Transplantation"},{"issue":"8","key":"10.1016\/j.cld.2007.08.001_bib151","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1365-2893.2006.00723.x","article-title":"Cytotoxic CD4 T cells in viral hepatitis","volume":"13","author":"Aslan","year":"2006","journal-title":"J Viral Hepat"},{"issue":"3","key":"10.1016\/j.cld.2007.08.001_bib152","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/hep.1840160308","article-title":"HBsAg retention sensitizes the hepatocyte to injury by physiological concentrations of interferon-gamma","volume":"16","author":"Gilles","year":"1992","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2007.08.001_bib153","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/0016-5085(92)90182-X","article-title":"High-level expression of hepatitis B viral antigens in fibrosing cholestatic hepatitis","volume":"102","author":"Lau","year":"1992","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.cld.2007.08.001_bib154","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1128\/JVI.80.6.2797-2807.2006","article-title":"Immune suppression uncovers endogenous cytopathic effects of the hepatitis B virus","volume":"80","author":"Meuleman","year":"2006","journal-title":"J Virol"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326107000815?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326107000815?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T01:53:33Z","timestamp":1684115613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326107000815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":154,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["S1089326107000815"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2007.08.001","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}